ABSTRACT

Objective: The study is to assess the resistin concentrations in Cardiovacular diseases and Other Co-morbidities of Cardiac patients. The underlying cause of cardiovascular diseases (CVD) and coronary artery disease (CAD) are understood to be inflammation. A significant factor in the etiology of CAD and HF are subclinical inflammations by resistin. Resistin adipokine is one of several pro-inflammatory indicators that can be used to identify the onset of a disease. In order to ascertain its correlation with CVD and other Co-morbidities.Method: There is 206 CVD patients were recruited for this study and then split into five groups based on the co-morbidities that were linked to them. Numerous biochemical and anthropometric markers like Resistin, Lipid profiles, blood glucose and BMI were evaluated. Results: The results were obtained that when compared to controls, CVD patients of Males, Type-2 Diabetes and CAD, HF were greater resistin levels than the females of CVDs and its subgroups had considerably higher and significant circulating levels of resistin. Point to a critical function of biomarker resistin in the onset of coronary artery disease and other cardiac problems. Conclusion: The current results found that there are co-morbid conditions such as type 2, diabetes, CAD, Hypertension can be a major contributing causes to the higher resistin levels in cardio vascular diseases. Keywords: Cardiovascular diseases, Resistin, Obesity, lipid profile and Type-2 Diabetes
Publication date: 15/03/2025

https://ijbpas.com/pdf/2025/March/MS_IJBPAS_2025_MARCH_SPCL_1084.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2025/14.3.1084